RecallGuide.ca
    Health productsUpdated Jan 3, 2026PFIZER CANADA ULCOfficial source

    Lidocaine Hydrochloride and Epinephrine Injection USP: Affected lot may contain particles.

    Share:

    In plain language

    This recall involves Lidocaine Hydrochloride and Epinephrine Injection USP, DIN 01901915, sold in Canada. It's being recalled because an affected lot may contain particles. Consult your healthcare provider before stopping use of the product and for any health concerns.

    What to do

    • Verify if your product is affected.
    • Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
    • Contact Pfizer Canada ULC if you have questions about the recall.

    Get alerts for recalls like this

    Get email alerts when new recalls affect products in this category.

    Categories (optional)

    No spam. Unsubscribe anytime. We only email when there's a relevant recall.

    Affected products

    • Lidocaine Hydrochloride and Epinephrine Injection USP

      Model: DIN 01901915

      Lot: LM4487

    Why this matters

    Product quality issue due to particles

    Do I have this product?

    This recall only applies to specific products. Follow the steps below to check.

    1. 1

      Check the product name

      Make sure your product name matches one of the affected products listed above.

    2. 2

      Check the lot number

      Lot numbers identify specific production batches.

      Affected lots: LM4487

    3. 3

      Check the model number

      Model numbers are typically on the product label or packaging.

      Affected models: DIN 01901915

    If your product matches one or more of the details above, it may be affected by this recall.

    If your product does not match these details, it is not affected by this recall.

    When in doubt, always check the official notice.

    Want alerts if similar products are recalled in Canada?

    Frequently Asked Questions

    Why was this product recalled?

    Product quality issue due to particles

    What should consumers do?

    Verify if your product is affected. Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns. Contact Pfizer Canada ULC if you have questions about the recall.

    Where was the product sold?

    This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.

    Is there a health risk?

    Yes, there may be a health risk. Product quality issue due to particles

    When was this product recalled?

    This product was recalled on April 29, 2025.

    Is the PFIZER CANADA ULC brand affected by this recall?

    Yes, PFIZER CANADA ULC products are affected by this recall. This recall involves Lidocaine Hydrochloride and Epinephrine Injection USP, DIN 01901915, sold in Canada. It's being recalled because an affected lot may contain particles. Consult your healthcare provider before stopping use of the product and for any health concerns.